Wan Yakun is the founder of Novamab. Novamab has raised $80M in total funding. Latest round: Series B+. Based in Shanghai, China.
Wan Yakun is the CEO and founder of Novamab Pharmaceuticals, a clinical-stage biotech company in Shanghai, China. He leads the company's efforts to develop life-changing therapies using innovative VHH technology, including inhaled single-domain antibody drugs for asthma treatment and a pipeline in autoimmune diseases.
Full founder directory · Investor directory · Company funding database · Fundraising library